氨酸通过代谢重编程抑制JAK1/2-STAT1通路来减弱M1巨细胞极化和IL-1β产生
Zi'an Zhang1, Danyue Li1, Suhui He1
1Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, China.
Biology
|December 30, 2025
概括
氨酸通过增加精氨酸来抑制M1巨分极和介素-1β (IL-1β) 释放,从而抑制JAK1/2-STAT1通路. 这一发现揭示了 taurine 的存在.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 代谢过程中的代谢.
背景情况:
- 巨细胞两极分化在诸如败血症和动脉样硬化等炎症性疾病中至关重要.
- 氨酸已知具有免疫调节作用,但其调节M1巨细胞和IL-1β生产的精确机制尚不清楚.
研究的目的:
- 为了研究 taurine 在调节巨细胞免疫代谢和炎症信号传递中的作用.
- 阐明 taurine 影响 M1 两极化和 IL-1β 生产的机制.
主要方法:
- 使用了由硫糖醇引起的腹膜巨细胞和巨细胞系.
- 采用了代谢学,分子生物学技术,JAK1/2-STAT1通路操纵和LPS诱导的小鼠败血症模型.
主要成果:
- 氨酸显著抑制了脂聚糖 (LPS) /干扰素-γ (IFN-γ) 诱导的M1极化.
- 代谢分析显示, taurine 诱导的精子积累,抑制了 JAK1/2-STAT1 的激活,并减少了 IL-1β 的释放.
- 在体内,牛治疗减轻了系统性炎症和器官损伤,在小鼠败血症模型中.
结论:
- 氨酸通过一种涉及精子积累和JAK1/2-STAT1抑制的新机制减弱M1极化和IL-1β产生.
- 氨酸对由M1巨细胞失调驱动的炎症性疾病具有治疗潜力.
关键词:
免疫代谢的免疫代谢.巨细胞是一个巨细胞.这是一种血症.精子 精子 精子 精子taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine taurine 是一种类型的氨基酸相关概念视频
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K


